Literature DB >> 29932608

[Analysis of lignans and their metabolites derived from Schisandra chinensis and vinegar Schisandra chinensis in rats’ plasma, bile, urine and faeces based on UHPLC-QTOF/MS].

Lian-lin Su, Xue Cheng, De Ji, Li-jun Wang, Xi-yan Ding, Tu-lin Lu, Chun-qin Mao, Ji Zhang.   

Abstract

UHPLC-QTOF/MS technique was used to study the differences of lignans and their metabolites derived from Schisandra chinensis and vinegar Schisandra chinensis in rat plasma, bile, urine and faeces by the data processing techniques such as the dynamic background subtract(DBS), mass defect filtering(MDF) and enhance peak list (EPL) in analysis. In order to enhance accuracy for Schisandra chinensis hepatoprotective effect, we established rat acute alcoholic liver injury model in this experiment, and studied the prototype components and metabolisms of Schisandra lignans in vivo under pathological condition. The main ingredients of alcohol extract are lignans, including deoxyschizandrin, schisandrin B, schizandrin C, schizandrol, schizandrol B,schisantherin, schisantherin B, schisanhenol, gomisin G, gomisin J. The metabolic transformation of lignans in rats was mainly induced by methylation, hydroxyl, oxidation, and so on. Finally, we identified 6 kinds of prototype components and their 20 potential metabolites in Schisandra chinensis group and vinegar Schisandra chinensis group.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 29932608

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  2 in total

1.  Pharmacokinetics and Main Metabolites of Anwulignan in Mice.

Authors:  Cong Chen; Yanbo Feng; Han Li; Hao Lin; Shu Jing; He Li; Chunmei Wang; Jianguang Chen; Jinghui Sun
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

Review 2.  Effects of processing adjuvants on traditional Chinese herbs.

Authors:  Lin-Lin Chen; Robert Verpoorte; Hung-Rong Yen; Wen-Huang Peng; Yung-Chi Cheng; Jung Chao; Li-Heng Pao
Journal:  J Food Drug Anal       Date:  2018-03-19       Impact factor: 6.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.